| Dr George N Little, DDS | |
|
7 Redwood Drive, Ross, CA 94957 | |
| (415) 925-2545 | |
| (415) 925-9220 |
| Full Name | Dr George N Little |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 7 Redwood Drive, Ross, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992997308 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 42847 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr George N Little, DDS 7 Redwood Drive, Ross, CA 94957 Ph: (415) 925-2545 | Dr George N Little, DDS 7 Redwood Drive, Ross, CA 94957 Ph: (415) 925-2545 |
News Archive
The Journal of Drugs in Dermatology is pleased to publish findings on a new injectable drug currently under development by Kythera Biopharmaceuticals, Inc. (Westlake Village, CA) that may provide a non-surgical alternative for people with double chins.
Salix Pharmaceuticals, Ltd. today announced that it has entered into an agreement to sell $300 million aggregate principal amount of its 2.75% convertible senior notes due 2015. In addition, Salix has granted the underwriters an overallotment option to purchase up to an additional $45 million aggregate principal amount of notes on the same terms and conditions.
This time of year parents in northern regions bundle up their children in preparation for winter activities. In addition to layers of warm clothing, gloves, and boots, parents often use whatever athletic headgear is available to mitigate the potential hazards of winter sports and play.
The results of a study presented today at the European League Against Rheumatism Annual Congress showed that the likelihood of achieving sustained remission in early rheumatoid arthritis (RA) is significantly lower in patients who smoke and who are obese.
AstraZeneca and Rigel Pharmaceuticals today announced an exclusive worldwide license agreement for the global development and commercialization of fostamatinib disodium (R788), Rigel's late-stage investigational product for rheumatoid arthritis (RA) and additional indications.
› Verified 1 days ago
Dr. Victoria Saykally, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 7 Redwood Dr, Ross, CA 94957 Phone: 415-925-2545 |